Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...
Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...
Daiichi Sankyo and Ambit Announce Results of Tender Offer PR Newswire TOKYO and SAN DIEGO, Nov. 10, 2014 TOKYO and SAN DIEGO, Nov. 10, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited...
Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation PR Newswire TOKYO and SAN DIEGO, Oct. 14, 2014 TOKYO and SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- On...
Daiichi Sankyo to Acquire Ambit Biosciences Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline PR Newswire TOKYO and SAN DIEGO, Sept. 29, 2014 TOKYO and SAN DIEGO...
Daiichi Sankyo to Acquire Ambit Biosciences PR Newswire TOKYO and SAN DIEGO, Sept. 29, 2014 -- Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline TOKYO and SAN DIEGO...
Daiichi Sankyo to Acquire Ambit Biosciences Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline PR Newswire TOKYO and SAN DIEGO, Sept. 28, 2014 TOKYO and SAN DIEGO...
Daiichi Sankyo Further Expands TaNeDS Collaborative Drug Discovery Program in Europe PR Newswire TOKYO, Sept. 1, 2014 TOKYO, Sept. 1, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (Tokyo...
Daiichi Sankyo Further Expands TaNeDS Collaborative Drug Discovery Program in Europe PR Newswire TOKYO, Sept. 1, 2014 TOKYO, Sept. 1, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (Tokyo...
Daiichi Sankyo and Charleston Laboratories Announce Collaboration to Develop and Commercialize Novel, Fixed-Dose Combination Hydrocodone Products for Pain and Opioid-Induced Nausea and Vomiting...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.97 | 10.319666435 | 28.78 | 32.05 | 28.67 | 126517 | 29.71833439 | DR |
4 | -0.35 | -1.09034267913 | 32.1 | 32.52 | 28.5 | 121090 | 30.21372913 | DR |
12 | -8.45 | -21.0199004975 | 40.2 | 40.6 | 28.5 | 93240 | 32.33219845 | DR |
26 | -2.75 | -7.97101449275 | 34.5 | 42.48 | 28.5 | 88878 | 34.29788394 | DR |
52 | 5.12 | 19.22643635 | 26.63 | 42.48 | 26.47 | 112778 | 32.48461156 | DR |
156 | 5.94 | 23.0143355289 | 25.81 | 42.48 | 19.39 | 121540 | 30.18084735 | DR |
260 | -31.185 | -49.5511241757 | 62.935 | 99.63 | 18.05 | 85069 | 30.64108285 | DR |
銘柄コード | 株価 | 出来高 |
---|---|---|
AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0.00275 (0.00%) | 51.06M |
GTEHGenTech Holdings Inc (CE) | US$ 0.000001 (0.00%) | 48.25M |
HMBLHUMBL Inc (PK) | US$ 0.0002 (-33.33%) | 42.65M |
CBGLCannabis Global Inc (PK) | US$ 0.00015 (50.00%) | 41.81M |
GTVHGolden Triangle Ventures Inc (PK) | US$ 0.0008 (33.33%) | 41.61M |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約